Lou Silverman Buys Shares of STAAR Surgical Company $STAA

Editorial illustration for STAAR Surgical Company (STAA)

Key Points

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Lou Silverman, insider at STAAR Surgical Company ($STAA), bought 6,182 shares at an average price of $0. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

STAAR Surgical Company Stock Up 30.4%

Shares of STAAR Surgical Company ($STAA) traded around $28.83 on Tuesday, up 30.4% for the day.

Last price$28.83
Market cap$1.13B
P/E ratio282.38
Forward P/E22.07
PEG ratio0.76
Beta1.23
52-week low$15.59
52-week high$35.87
50-day MA$25.55
200-day MA$24.09
Current ratio4.67
Quick ratio3.86
Debt-to-equity0.10

STAAR Surgical Company Earnings

EPS (ttm)$0.08
Revenue (ttm)$339.59M
Revenue growth111%
Net margin1.13%
Return on equity1.09%
Next earningsNov 11, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$27.90
High target$37
Low target$19
Analysts covering10

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

ExchangeNasdaqGM
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersLake Forest, CA
CEOMs. Deborah J. Andrews
Employees921

Get STAAR Surgical Company alerts

New 13F filings, insider trades, and analyst moves on $STAA, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.